Jobs / United States / Natera INC
Regional Director, GU Oncology Sales
Natera INC · 🇺🇸 East, US Region
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 48 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 12 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Natera INC paid sponsored hires in similar roles1 certified filing for “Senior Director, Business Development” (Sales Managers) in CA: $246k–$246k, median $246k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Natera INC
The US Department of Labor certified 48 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 12 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Natera INC →
About the role
Location: East US Region Natera is seeking an experienced Regional Director to build, lead, and develop a team of Clinical Oncology Specialists focused on Genitourinary (GU) cancers across the Eastern United States. This specialized sales team will drive adoption of Natera’s Signatera™ molecular residual disease (MRD) test , with a primary focus on Urologic Oncology. Key call points include Urologic Oncologists, GU Surgical Oncologists, Radiation Oncologists, Medical Oncologists, Pathologists, and other healthcare providers involved in the diagnosis, treatment, and ongoing management of patients with genitourinary cancers. Signatera is a personalized, tumor-informed circulating tumor DNA (ctDNA) assay designed to detect molecular residual disease and monitor disease recurrence. Across GU cancers, including bladder, renal cell carcinoma, and testicular cancers, Signatera provides highly specific molecular insights that can help clinicians better assess recurrence risk, monitor disease status, and inform individualized patient management strategies. The Regional Director will drive sales performance, ensure sales goals and management objectives are achieved or exceeded, and collaborate with cross-functional teams to develop and execute business strategies aligned with Natera Oncology's broader corporate objectives. Key Responsibilities • Hire, coach, develop, and lead a team of approximately 10 Clinical Oncology Specialists focused on GU cancers, driving Signatera adoption and achieving regional sales objectives. • Establish a strong field leadership presence through strategic business planning, coaching, CRM utilization, Core Oncology Sales collaboration, and regular field engagement. • Develop and execute regional sales strategies targeting Urologic Oncologists, GU Surgical Oncologists, Medical Oncologists, Pathologists, and other key stakeholders across academic and community oncology settings. • Build and strengthen relationships with Key Opinion Leaders (KOLs) specializing in GU cancers, particularly within major academic medical centers, leading urology practices, and community oncology networks. • Drive awareness, education, and adoption of Signatera within GU Oncology, with an emphasis on bladder, kidney, and testicular cancers. • Develop expertise in Natera's molecular diagnostics technology, clinical evidence, and service offerings, effectively representing the company with KOL physicians, academic and community medical directors, and executive-level stakeholders. • Oversee recruitment, hiring, onboarding, training, and performance development of GU Clinical Oncology Specialists. • Conduct regular field visits with sales professionals to provide coaching, reinforce clinical and commercial knowledge, and support individual and team performance. • Collaborate closely with Natera's Core Oncology Sales team and cross-functional partners to align account strategies, expand market opportunities, and maximize commercial effectiveness. • Monitor market trends, competitive dynamics, and evolving clinical evidence in GU Oncology to identify opportunities for growth and regional expansion. • Develop and execute regional business plans aligned with sales objectives, market opportunities, and available resources. • Optimize regional and territory alignment to maximize market coverage, sales productivity, and return on investment. • Establish best practices for territory management, strategic account planning, physician engagement, and sales execution. • Attend relevant local, regional, and national oncology and urology conferences, industry meetings, and training sessions. • Support career development and succession planning by providing ongoing mentorship and leadership development opportunities. • Ensure all empl